Clinical trial Recruiting at 1 site Interventional

Understanding genetic syndromes linked to RNU4ATAC mutations

Official title: Study of the Consequences of Mutations of the RNU4ATAC and RTTN Genes by Transcriptomic, Biochemical and Cellular Approaches in Order to Determine the Pathophysiology of Their Associated Syndromes: Microcephalic Osteodysplastic Primordial Dwarfism Type I/III, Roifman Syndrome and Lowry-Wood Syndrome

Run by Hospices Civils de Lyon · NCT06111950 · Data updated 2026-11-12

This study is trying to understand how changes in the RNU4ATAC gene affect rare genetic syndromes like Taybi Linder Syndrome and Roifman Syndrome, which can cause growth and developmental problems.

Quick facts

Study typeInterventional
SexAll
Enrollment45 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations6 sites (Bordeaux and 5 other locations)
StatusRecruiting
StartedAugust 27, 2024
Main results expectedAugust 27, 2029
Study endsAugust 27, 2029
Registry record updatedOctober 9, 2024
Trial IDNCT06111950 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with Taybi Linder Syndrome, Roifman Syndrome, Lowry Wood Syndrome, or other related conditions with specific RNU4ATAC mutations.

Probably not a fit

Patients without bi-allelic mutations of RNU4ATAC or RTTN, or those not diagnosed with the specified syndromes, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the pathophysiology of rare genetic syndromes associated with mutations in the RNU4ATAC gene, which is involved in the minor spliceosome. It focuses on conditions such as Taybi Linder Syndrome, Roifman Syndrome, and Lowry Wood Syndrome, which are characterized by growth retardation, microcephaly, and other developmental issues. The research involves collecting blood samples, skin biopsies, and fetal samples to explore the impact of minor splicing defects on U12 genes that are crucial for primary cilia function. The goal is to better understand the cellular mechanisms affected by these mutations.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and potential treatments for patients with these rare genetic syndromes.

How similar studies have gone: While this approach is novel in its specific focus on RNU4ATAC mutations, similar studies on genetic syndromes have shown promise in understanding underlying mechanisms.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

TALS, RFMN, LWS or other pathology patients

* Woman or man
* All ages
* Presence of bi-allelic mutations of RNU4ATAC or RTTN
* Written consent of parents or legal guardian(s)
* Affiliation to a Social Security scheme

Healthy participants (Parent of the patient)

* Woman or man
* Major
* Presence of mono-allelic mutations of RNU4ATAC
* Written consent of the participant
* Affiliation to a Social Security scheme

Parents having recourse to a medical termination of pregnancy or having had a spontaneous miscarriage (for fetus samples)

* Woman or man
* Major
* Presence of bi-allelic mutations of RNU4ATAC or RTTN in the fetus
* Written parental consent
* Affiliation to a Social Security scheme

Exclusion Criteria:

Subject participating in another research including an exclusion period still in progress.

Where it's running

  • Centre de référence anomalies du développement de Lyon, Hôpital Femme Mère Enfant
    Bron, France
    Recruiting
  • Centre de référence des anomalies du développement et syndromes malformatifs du Sud-Ouest Occitanie Réunion, CHU de Bordeaux-GH Pellegrin
    Bordeaux, France
    Not yet recruiting
  • Centre de référence des anomalies du développement et syndromes malformatifs de l'Est, CHU de DIJON
    Dijon, France
    Not yet recruiting
  • Centre de référence des anomalies du développement et syndromes malformatifs de l'inter région Nord-Ouest, Hôpital J de Flandre
    Lille, France
    Not yet recruiting
  • Unité Fonctionelle d'embryo-fœtopathologie, Hôpital Necker-Enfants Malades
    Paris, France
    Not yet recruiting
  • Centre de référence des anomalies du développement et syndromes malformatifs de l'Ouest, Hôpital Sud
    Rennes, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.